Goldman Sachs Aktienanleihe MUV2 .../ DE000GG7DGR5 /
21/06/2024 09:52:37 | Chg.+0.04 | Bid22:00:40 | Demandez à22:00:40 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
106.17EUR | +0.04% | - Bid taille: - |
- Ask la taille: - |
MUENCH.RUECKVERS.VNA... | 500.00 - | 26/03/2025 | Call |
GlobeNewswire
03:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Dir...
GlobeNewswire
02:45
Novotech Liver Cancer Research Landscape Report Finds 1,700 Trials Initiated Globally
GlobeNewswire
01:44
ROSEN, LEADING INVESTOR COUNSEL, Encourages UiPath, Inc. Investors to Secure Counsel Before Importan...
GlobeNewswire
01:35
ROSEN, LEADING INVESTOR COUNSEL, Encourages NIKE, Inc. Investors to Secure Counsel Before Important ...
GlobeNewswire
22/06
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MacroGenics, In...
GlobeNewswire
22/06
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Masimo Corporati...
GlobeNewswire
22/06
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FutureFuel Corp....
GlobeNewswire
22/06
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bolt Biotherapeu...
GlobeNewswire
22/06
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron Pharma...
GlobeNewswire
22/06
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Hesai Group - HS...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page